pembrolizumab,lenvatinib,rivoceranib,camrelizumab
Merck,jiangsu hengrui pharmaceuticals,elevar therapeutics,eisai
['hcc', ' cam ']
leap 02 vs cam rivo . why one failed and other not? dose viral etiology of hcc and asian pts matter ? #esmo22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists